Atlas Private Wealth Advisors Decreases Holdings in MetLife, Inc. (NYSE:MET)

Atlas Private Wealth Advisors trimmed its holdings in shares of MetLife, Inc. (NYSE:METFree Report) by 6.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,136 shares of the financial services provider’s stock after selling 200 shares during the quarter. Atlas Private Wealth Advisors’ holdings in MetLife were worth $257,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the business. Zurich Insurance Group Ltd FI purchased a new stake in MetLife in the 3rd quarter worth about $91,771,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its stake in MetLife by 79.1% in the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,726,209 shares of the financial services provider’s stock worth $142,378,000 after acquiring an additional 762,291 shares in the last quarter. Jacobs Levy Equity Management Inc. grew its stake in MetLife by 256.6% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 948,223 shares of the financial services provider’s stock worth $78,209,000 after acquiring an additional 682,333 shares in the last quarter. Nordea Investment Management AB grew its stake in MetLife by 16.8% in the 4th quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock worth $347,735,000 after acquiring an additional 608,224 shares in the last quarter. Finally, SG Americas Securities LLC grew its stake in MetLife by 107.5% in the 4th quarter. SG Americas Securities LLC now owns 30,542 shares of the financial services provider’s stock worth $2,501,000 after acquiring an additional 435,807 shares in the last quarter. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. JPMorgan Chase & Co. upped their target price on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 7th. TD Cowen upped their target price on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research note on Wednesday, November 27th. Wells Fargo & Company dropped their price objective on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 14th. Jefferies Financial Group increased their price objective on shares of MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research note on Friday, September 27th. Finally, BMO Capital Markets started coverage on shares of MetLife in a research note on Thursday. They set a “market perform” rating and a $97.00 price objective on the stock. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, MetLife has a consensus rating of “Moderate Buy” and a consensus price target of $90.46.

Get Our Latest Research Report on MET

MetLife Trading Down 0.9 %

NYSE MET opened at $85.96 on Friday. The company has a fifty day simple moving average of $83.76 and a two-hundred day simple moving average of $79.87. The stock has a market cap of $59.52 billion, a P/E ratio of 17.33, a P/E/G ratio of 0.65 and a beta of 1.07. MetLife, Inc. has a 12-month low of $64.61 and a 12-month high of $89.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51.

MetLife Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be issued a $0.545 dividend. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.54%. MetLife’s dividend payout ratio is currently 43.95%.

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Stories

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.